Bradley Foster & Sargent Inc Praxis Precision Medicines, Inc. Transaction History

Bradley Foster & Sargent Inc

  • $5.82 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$1.75 - $11.34 $19,250 - $124,740
-11,000 Closed
0 $0
Q2 2021

Aug 19, 2021
BUY
$18.28 - $33.05 $73,120 - $132,200
4,000 Added 57.14%
11,000 $201,000
Q4 2020

Feb 11, 2021
BUY
$27.25 - $55.82 $190,750 - $390,740
7,000 New
7,000 $385,000

Others Institutions Holding PRAX

# of Institutions
1
Shares Held
75K
Call Options Held
0
Put Options Held
0
View Full List

About Praxis Precision Medicines, Inc.

PRAX Quotes by TradingView
  • Ticker PRAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,576,100
  • Market Cap $3.33B
  • Description
  • Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...
More about PRAX
Track This Portfolio

Track Bradley Foster & Sargent Inc Portfolio

Follow Bradley Foster & Sargent Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bradley Foster & Sargent Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email